Fábio C. P. Navarro

Universidade Federal de Alfenas — Brazil

Biochemistry, Genetics and Molecular Biology · Life Sciences

54h-index35.5kcitations186works7.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(57), Immunotherapy and Immune Responses(28), Monoclonal and Polyclonal Antibodies Research(25), RNA modifications and cancer(21), vaccines and immunoinformatics approaches(21)

Publications123 total

Broad Utility of Ultrasensitive Analysis of ctDNA Dynamics across Solid Tumors Treated with Immunotherapy
Clinical Cancer Research·2025· 1 citedOpen Access
Longitudinal ultrasensitive ctDNA monitoring for high-resolution lung cancer risk prediction
Cell·2025· 3 citedOpen Access
A remarkable small local natural radiation anomaly in Poços de Caldas, Brazil
The European Physical Journal Special Topics·2025· 2 cited
Circulating tumor DNA, pathologic response after neoadjuvant therapy, and survival: First results from TBCRC 040 (the PREDICT-DNA trial).
Journal of Clinical Oncology·2025· 8 cited
Abstract 3774: Detection of post-surgical minimal residual disease (MRD) in colorectal cancer; preliminary results from the VICTORI study
Cancer Research·2025
Abstract 4549: Impact of an ultrasensitive ctDNA test on MRD detection in real world clinical patient testing
Cancer Research·2025· 1 cited
Whole genome sequencing-powered ctDNA sequencing for breast cancer detection
Annals of Oncology·2025· 30 citedOpen Access
Identifying the optimal post-surgical timing of molecular residual disease (MRD) detection in colorectal cancer (CRC) using an ultra-sensitive assay: Interim results from the VICTORI study.
Journal of Clinical Oncology·2025· 1 cited
Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma
Nature Medicine·2025· 52 citedOpen Access
Ultra-sensitive, tumor-informed ctDNA profiling in pembrolizumab-treated esophagogastric cancer patients predicts clinical responses
2024Open Access
223P Tumor whole genome sequencing-based ultrasensitive ctDNA analysis as an early biomarker for clinical outcome in immune checkpoint inhibitor (ICI) phase I clinical trials (Ph1) and a tool for beyond progressive disease by iRECIST
Annals of Oncology·2024· 1 citedOpen Access
Ultra-sensitive ctDNA dynamics to capture therapy response in pembrolizumab-treated gastroesophageal cancer.
Journal of Clinical Oncology·2024· 1 cited
Circulating tumor DNA (ctDNA) kinetics in colorectal cancer (CRC) treated with curative intent in the VICTORI study with an ultrasensitive MRD assay.
Journal of Clinical Oncology·2024· 1 cited
Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay
Oncotarget·2024· 24 citedOpen Access
Analytical Validation of NeXT Personal <sup>®</sup> , an Ultra-sensitive Personalized Circulating Tumor DNA Assay
2024Open Access
Correction: Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay
Oncotarget·2024· 1 citedOpen Access
Large healthy donor dataset demonstrates high analytical specificity and repeatability for the NeXT Personal molecular residual disease assay.
Journal of Clinical Oncology·2023
Abstract 3381: Analytical performance of an ultra-sensitive, tumor-informed liquid biopsy platform for molecular residual disease detection and clinical guidance
Cancer Research·2023
Supplementary data tables from STK11/LKB1 Loss of Function Is Associated with Global DNA Hypomethylation and &lt;i&gt;S&lt;/i&gt;-Adenosyl-Methionine Depletion in Human Lung Adenocarcinoma
2023Open Access
Supplementary Table from Prediction of Immunotherapy Response in Melanoma through Combined Modeling of Neoantigen Burden and Immune-Related Resistance Mechanisms
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Mark Gerstein(33), Jan O. Korbel(15), Ken Chen(14), Yilong Li(14), Kadir C. Akdemir(14), Peter J. Park(14), Nicola D. Roberts(11), Jeremiah A. Wala(11), Steven E. Schumacher(11), Eva G. Álvarez(11), Adrian Baez‐Ortega(11), Kathleen H. Burns(11), Isidro Cortés‐Ciriano(11), Young Seok Ju(11), Eunjung Alice Lee(11), Iñigo Martincorena(11), Montserrat Puiggròs(11), James E. Haber(10), Marcin Imieliński(10), Dmitry A. Gordenin(10)